Subject: Amendments to Rule 15c2-11 - File No. S7-5-99
Author:  JoAnn Rushing <Joann@AMEDISYS.COM>
Date:    4/6/99 12:19 PM
     
     
Attn:  Jonathan G. Katz
     
Dear Mr. Katz:
     
As a public company traded on the NASD OTC Bulletin Board, we are 
concerned and would like to voice our opposition to proposed 
amendments to Rule 15c2-11.
     
While we are in full agreement that all steps possible should be taken to 
deter fraud in the microcap markets, we do not believe these
amendments are the answer.  Our fear is, that should these amendments 
pass, those of us who are traded in the microcap market will suffer the 
consequences of the impossible burden imposed on brokers.  These 
proposed requirements are unrealistic and will cause market makers to 
cease trading in stocks such as ours.
     
Sincerely,
     
Joann B. Rushing
Executive Vice President
Amedisys, Inc.